K-numberK250874
Device nameSunrise
ApplicantSunrise SA
Product codeQRS
Device classClass II
Decision dateAug 29, 2025
DecisionSubstantially Equivalent
Regulation868.2376
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Sunrise Air is a non-invasive home care device that evaluates obstructive sleep apnea (OSA) in patients 18 years and older suspected of having sleep breathing disorders. It consists of a small wearable sensor placed on the chin and software that analyzes mandibular movement, respiratory effort, airflow, oxygen saturation, pulse rate, and snoring to generate sleep parameters and an apnea-hypopnea index (AHI) for healthcare provider interpretation.

Technological characteristics

The Sunrise Air adds two enhancements to the predicate Sunrise device: a microphone for snore detection and a rechargeable lithium-ion battery (~500 charging cycles) instead of a non-rechargeable coin cell. The optical module, thermistor, accelerometer, and gyroscope remain identical. The device retains cloud-based analysis of sleep parameters and the same physical footprint and wearable form factor worn on the chin with adhesive.

Test standards cited

IEC 60601-1 (basic safety), IEC 60601-1-2 (electromagnetic compatibility), IEC 60601-1-11 (home healthcare environment use), and ISO 10993-1 (biocompatibility evaluation). Software verification and validation followed FDA guidance for device software functions; cybersecurity measures were documented per FDA cybersecurity guidance.

Substantial equivalence argument

The Sunrise Air is substantially equivalent because it performs the same intended function as the predicate Sunrise device with identical core sensor technology (optical module, thermistor, accelerometer, gyroscope) and unmodified sleep analysis algorithms. The additions of a microphone and rechargeable battery are minor enhancements: microphone performance was validated as comparable to the reference device, and the rechargeable battery poses no safety or effectiveness concern. Bench testing confirmed signal equivalence, and PPG-derived SpO₂ and pulse rate accuracy met predicate-level performance (SpO₂ 1.91% rms error, pulse rate 2.73 bpm rms error).

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →